Health checks could start at 30 in 'national first'
People living in a seaside town could be offered health checks from the age of 30 in a national first for the NHS, a senior doctor said.
The free screening is usually offered to those aged 40 to 74, but that could be lowered in Clacton-on-Sea to tackle health inequalities.
Dr Ed Garrett revealed the plan at a Suffolk and North East Essex Integrated Care Board (ICB) meeting on Tuesday and said it was "progressing" forward.
But an NHS spokesman said the idea was "very early stages".
The health check aimed to detect if people were at higher risk of getting certain illnesses, including heart disease, diabetes and strokes.
It involved screenings, including cholesterol and blood pressure tests.
Dr Garrett said it would be a "national first" if the proposal went ahead.
"Given life expectancy [in Clacton], we feel it's important that health checks are delivered earlier," he said.
The seaside town has been the focus of concerted efforts by the NHS to stop deprivation leading to health inequalities.
Chief Medical Officer Sir Chris Whitty visited in 2021, having authored the Coastal Communities report.
In it, he said these towns suffered from high rates of serious illnesses and lower life expectancy among residents.
Ian Davidson, chief of Tendring District Council, also said people living in some parts of Clacton had a life expectancy 18 years lower than in wealthier parts of Essex.
When approached by the BBC to provide more details on its health checks plan, an ICB spokesman said it was still in its infancy.
He added: "We'll share more details as soon as we are able."
Follow Essex news on BBC Sounds, Facebook, Instagram and X.
Life expectancy gap of 18 years in parts of Essex
Whitty: Deprived coastal towns need redesign
Seaside poor health overlooked, warns Whitty
Suffolk and North East Essex ICB
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
NHS calls for 200,000 new blood donors as supplies run low
The NHS has warned that it continues to face a "challenging" blood shortage, as it calls for 200,000 new donors to come forward. Concern over blood stocks prompted the health service to issue an "amber alert" last year, meaning supplies were running low enough to have an impact on patient treatment. Supplies have remained low ever since, with officials warning there is a "critical" need for more donors who have O negative blood, which can be given to the majority of patients. NHS Blood and Transplant (NHSBT), the body that oversees England's blood donation system, said the number of regular donors needs to rise from around 800,000 to more than one million to maintain a safe and reliable supply. NHSBT chief executive Dr Jo Farrar said: "Our stocks over the past 12 months have been challenging. If we had a million regular donors, this would help keep our stocks healthy - you'd truly be one in a million." There is a pressing need to avoid a "red alert", which would mean demand far exceeds capacity, threatening public safety, NHSBT added. The body's chief medical officer said such an alert could see patients waiting longer for treatment. Dr Gail Miflin told BBC Radio 4's Today programme: "It can mean, if you're not urgently needing blood, that you may be delayed or have an operation delayed. "But if you really need blood you'll still get it." Four-year-old Isaac receives transfusions every 12 weeks, which he calls "Hulk blood" because it makes him feel strong. Born with Spherocytosis, a condition which affects the red blood cells, he regularly becomes severely anaemic. His mother, Jasmin, said the "superhero blood" works like "magic" for Isaac, and that the shortage was worrying. "Everybody lives such busy lives. It isn't always a priority until it's someone you know or it's yourself that needs a transfusion," she told BBC Breakfast. Health Minister Baroness Merron said the NHS was in "urgent need" of more blood donors from all backgrounds. "We are working alongside NHS Blood and Transplant to make donating blood easier than ever before, opening up new donor centres and making appointments available closer to home," she added. NHSBT stressed the need for more black donors in particular, as they are more likely to have specific blood types which can help treat people with sickle cell disease. Just 2% of the population keep the nation's blood stocks afloat by donating regularly, the body said. Donors are defined as regular if they have donated in the last 12 months. The number of people registering as donors rose in 2024, but only 24% of them went on to donate. The appeal comes almost a year after the NHS issued an amber alert for only the second time in its history, last July. It was caused by what the NHS called a "perfect storm" of unfilled appointments at donor centres and increased demand following a cyber-attack, which affected services in London. At that time, stocks of O negative stood at just 1.6 days, and 4.3 days for all types of blood. Two thirds of the blood collected by NHSBT is used to treat people who rely on regular blood transfusions, including people with cancer and blood conditions. Those who want to give blood can register and book an appointment online. Get our flagship newsletter with all the headlines you need to start the day. Sign up here.
Yahoo
2 hours ago
- Yahoo
The cost of caring for a loved one
It's Carers' Week, when we're encouraged to recognise the effort put in by unpaid carers looking after their loved ones. As more people live longer and need more care, it should also be a chance to consider what we'd do if we found ourselves in this position, and someone we love needed care. You might want to step in and help, so it's worth understanding the potential costs — from the extras you'd need at home to the cost of any lost income. In many cases, the whole family will need to have a frank conversation about how to support the person offering care, as well as the person needing it. If your family member needs professional care, the question of costs becomes even more pressing. On average, you'll pay about £50,000 a year for residential care and £66,000 for a nursing home, but the averages hide some big costs, and plenty of people pay well over £100,000 a year. You may be able to get some help from the state, but there's a process you need to go through first. It starts with a "needs assessment", done by your local authority, who will work out what care the person needs. Read more: How much does it cost to become a driver in the UK? Next you go through a financial assessment, which looks at the assets of the person needing care. If they're getting care at home, or they're in a care home temporarily, this assessment won't include the value of their own home. If they're going into a care home permanently, it may include their home, unless someone from specific groups also lives there. This includes a partner, any of their children under the age of 18, or a relative who is disabled or over the age of 60. In England, if they have assets of less than £14,250, the council may pay for care — although it will also take their income into account. If they have between £14,250 and £23,250, they will have to contribute to the cost of care, but if they have assets over £23,250, they'll need to foot the entire bill. If your loved one has complex medical needs, they should be assessed for NHS Continuing Healthcare. This can pay for all their care in some cases, but don't assume they'll qualify. It's not enough to have caring needs around the clock, they'll have to have very high medical needs too, requiring regular intervention from medical experts and professionals. If you end up needing to pay for care for someone, there are a few benefits that will help. If they are over state pension age, they could get the attendance allowance — or pension age disability in Scotland. However, this will barely scratch the surface of costs. It means you may need to speak to anyone in your life who might need care, to see what preparations they've put in place. A piece of research we did a while ago found that fewer than half of people thought their loved ones could pay for care from their savings. It means you should consider their pension too. A guaranteed monthly pension income will go towards the cost of care. If they're using pension drawdown, they may have money in their pension pot that can be used too. For younger people, this often makes sense as a way to save for your own care needs, especially if you're saving into a workplace pension and your employer is helping to build the pot. Read more: What is the Pension Investment Review? However, the value of the property will often need to be used. Some people will rent the family home out to cover fees, although this is risky because rental income isn't guaranteed, and will be depleted by maintenance and repairs. You can consider equity release to free up some of the value in the property, but this is expensive. There will be a set up cost, and usually any interest on the loan will roll up, and needs to repaid when the property is sold. There's also the option of a deferred payment arrangement with the local council, which is a bit like equity release, but run by the council and slightly less expensive. But for many people, the most sensible option ends up being selling up. You might pay fees from the lump sum as you go along, but it's worth considering an immediate needs care annuity instead. These pay a fixed amount to the care home every month for the rest of their life, and tend to cover the gap between pension income and the cost of care. Talking to your loved ones about care, and how they'd pay for it, is difficult, but it's a far easier conversation well in advance, when they have time to make a plan. It's much more stressful to try to discuss this at the point they already need care and are starting to panic about how they're going to pay for more: How to tell if you're rich Should people keep working until later in life? How to get your children to move outSign in to access your portfolio
Medscape
2 hours ago
- Medscape
Less Invasive Screening May Identify Barrett's Earlier
A new combination modality demonstrated excellent sensitivity and negative predictive value compared with endoscopy in a prospective study of at-risk veterans screened for Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC), a small comparative study in US veterans found. BE is up to three times more prevalent in veterans than in the general population. This and other minimally invasive approaches may reduce patient anxiety and increase screening rates, according to investigators led by Katarina B. Greer, MD, MS, of the VA Northeast Ohio Healthcare System and Case Western University in Cleveland. Such screening platforms are expected to open a window on improved prognosis for EAC by offering well-tolerated, office-based testing, the authors wrote in The American Journal of Gastroenterology. Greer and colleagues compared standard upper endoscopy with EsoCheck (EC), a nonendoscopic esophageal balloon cell-sampling device coupled with EsoGuard (EG), a DNA-based precancer screening assay, with standard upper endoscopy, an FDA-approved minimally invasive alternative. Sensitivity and specificity of combined EC/EG for esophagogastroduodenoscopy (EGD)-detected BE/EAC were 92.9% (95% CI, 66.1-99.8) and 72.2% (95% CI, 62.1-80.8), respectively. Positive and negative predictive values were 32.5% (95% CI, 18.6-49.1) and 98.6% (95% CI, 92.4-100), respectively. 'With its strong negative predictive power, this screening modality could be a first-line tool available to a greater number of patients,' Greer and associates wrote. 'Data from this test support the notion that EC could be performed as a triaging test to increase the yield of diagnostic upper endoscopy 2.5-fold.' The US rates of EAC have increased more than six-fold in the past four decades and continue to rise. In 2023, 21,560 cases of EAC were diagnosed here. The prognosis for EAC is still poor, with fewer than 22% of patients surviving beyond 5 years. Current guidelines recommend sedated EGD for patients with chronic gastroesophageal reflux disease (GERD) and additional BE risk factors such as smoking, obesity, and family history. This strategy, however, often fails to detect BE when symptoms are well controlled with over-the-counter or physician-prescribed therapies, Greer and colleagues noted. It also fails to detect BE in individuals without GERD, who comprise 40% of those who develop EAC. Fewer than 5% of EACs are diagnosed as early-stage lesions caught by surveillance of patients with previously detected BE. Study Details The researchers recruited veterans meeting American College of Gastroenterology criteria for endoscopic BE and EAC screening at the Louis Stokes Cleveland Veterans Affairs Medical Center. Of 782 eligible veterans, 130 (16.6%) entered the study and 124 completed screening. Common reasons for nonparticipation included completion of upper endoscopy outside of the VA healthcare system, lack of interest in joining a research study, and no recommendation for screening from referring gastroenterology or primary care providers. Eligible candidates had gastroesophageal reflux disorder plus three additional risk factors, such as smoking, higher BMI, male sex, age 50 years or older, and family history. The mean number of risk factors was 4.1. 'Available data suggest that family history is the strongest predictor of BE diagnosis, as prevalence of BE among those with family history was 23%,' Greer's group wrote. 'This points to high priority of pursuing screening in patients with family history of the condition, followed by patients who share multiple risk factors.' All participants completed unsedated EC-guided distal esophageal sampling followed by a sedated EGD on the same day. The prevalence of BE/EAC was 12.9% (n = 14/2), based on standard EGD. 'The study was not powered to prospectively determine EC diagnostic accuracy for subgroups of nondysplastic and dysplastic BE and EAC. These data are reported for this device in development studies but not available for our study population,' the authors wrote. In comparison, they noted, the Cytosponge-TFF3, another nonendoscopic screening device for EAC and BE, exhibited lower sensitivity of 79.5%-87.2%, depending on lesion length, but higher specificity of 92.4%. Procedural Anxiety Baseline scores on the short-form six-item Spielberger State-Trait Anxiety Inventory-6 (STAI-6) revealed notable levels of periprocedural anxiety. STAI-6 scores range from 20 to 80, with higher scores indicating more severe anxiety. In the VA study, scores ranged from 20 to 60, and most domains constituting the scores were the same before and after the procedure. Participants did, however, report a statistically significant decrease in sense of worry after EC and reported good tolerability for both EC and EG. Offering an outsider's perspective on the study, Joshua Sloan, DO, an esophageal gastroenterologist at University of Minnesota Medical Center in Minneapolis, said that with the acceleration of US rates of EAC, developing a nonendoscopic screening tool to improve identification of Barrett's and perhaps early EAC is important. 'The study by Greer et al helps support the use of nonendoscopic screening with EsoCheck and EsoGuard to identify these conditions,' he told Medscape Medical News. 'It will be interesting to see similar studies in the non-VA population as well. As the study notes, veterans are an enriched population with a higher prevalence of Barrett's esophagus.' Ultimately, Sloan added, 'the hope is to increase our ability to identify and manage BE before it becomes EAC. Nonendoscopic screening tools have the potential to increase diagnosis and funnel the appropriate patients for endoscopic surveillance.' The Bottom Line 'Calculations regarding effectiveness of the two-step screening strategy afforded by EC indicate that the burden of screening would be reduced by at least half (53%),' the authors wrote. Since the estimated size of the US screen-eligible population ranges from 19.7 million to 120.1 million, noninvasive tools could significantly decrease EGD procedures. A formal cost effectiveness analysis is being conducted and will be published separately. This study was funded by a Department of Defense award.
